Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer : TNBC-RT2023

NCT06418126 is registered in ClinicalTrials.gov with Centre Paul Strauss as lead sponsor.

NCT NCT06418126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06418126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer : TNBC-RT2023
Lead sponsor
Centre Paul Strauss
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 11, 2024
Completion date
August 19, 2030
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple-negative breast cancer